Status:
COMPLETED
Patient's Management Receiving Eplerenone Therapy
Lead Sponsor:
Pfizer
Conditions:
Left Ventricular Dysfunction Post Myocardial Infarction
Eligibility:
All Genders
18-95 years
Brief Summary
On a population of patients followed by an office-based cardiologist and treated with eplerenone, the objectives of the survey are: * To describe the characteristics of the population treated. * To d...
Detailed Description
A sample size in the region of N = 400 patients will allow this accuracy of estimation, as for this size, the half-width would be equal to 5% for a frequency of 50% corresponding to a confidence inter...
Eligibility Criteria
Inclusion
- The following patients may be selected to participate in the survey:
- Those undergoing treatment with eplerenone in accordance with the MA or not, with a known start date.
- Those likely to be followed by the same physician for a minimal period of twelve months.
Exclusion
- Severe Kidney Disease
- Hyperkamiemia more than 5.5
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01440049
Start Date
September 1 2008
End Date
December 1 2010
Last Update
December 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.